Description

Tirzepatide — Dual GIP/GLP-1 Receptor Agonist

Tirzepatide is a novel synthetic peptide that acts as a dual agonist of both the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. This dual mechanism has made it one of the most studied peptides in modern metabolic research.

Research Applications

Tirzepatide has been investigated for its effects on glucose regulation, insulin sensitivity, appetite signaling and body-weight research models. By engaging two incretin pathways simultaneously, it serves as a key reference compound in studies of energy balance and metabolic function.

Specifications

• Purity: ≥99% (HPLC verified)
• Quantity: 30mg per vial
• Form: Lyophilized powder
• Storage: Store at -20°C; reconstituted solution stable at 2–8°C for up to 14 days
• CAS: 2023788-19-2

For laboratory and research use only. Not for human or animal consumption.